Articles, guides, and regulatory updates from our community.
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in liver cancer. Learn what this study found and what it means for patients.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in liver cancer. Learn what this preclinical study found.
By Peptide Association Research Team